The myeloma and macroglobulinemia treatment group provides diagnosis, prognosis, and treatment strategies to patients with the following blood and marrow problems:
Although patients with abnormal elevation of the protein (immunoglobulin proteins or antibodies) are detected when they have no symptoms and have no active cancer form of the disease, it's important to have them evaluated promptly. When changes are detected early, more treatment options are usually available, increasing the likelihood preventing complications and establishing good long-term management strategies.
Doctors in the myeloma and macroglobulinemia treatment group include:
For a list of recent publications by members of our group please refer to the links above. The treatment group at Mayo Clinic in Arizona offers:
Many patients are referred to us for treatment counseling and for consideration of participation in clinical trials. The treatment group develops an individualized, comprehensive treatment plan, thoroughly reviewing the options available for each patient. The team of health care professionals in the myeloma and macroglobulinemia team includes:
This multidisciplinary approach helps to ensure each patient's needs are met and the most effective medical care is provided. Most services and treatments are provided in one facility for the convenience of the patient. Care is given in a supportive environment, and consultation rooms and imaging areas are comfortable.
The Mayo Clinic myeloma and macroglobulinemia treatment groups in Arizona and Rochester work closely with one another.
Our Arizona group offers participation in clinical trials that incorporate novel agents into the treatment of these conditions such as:
Our research activities also offers patients an opportunity to participate in research projects aimed at better understanding the causes and consequences of myeloma and macroglobulinemia:
Our group has received research support from many sources including:
If you have an interest in the philanthropic support of research related to myeloma and macroglobulinemia, please click here for more information about the Mayo Clinic Department of Development.
Mayo's clinical trials include experimental treatments, often unavailable elsewhere, which frequently lead to improved patient care for people worldwide. We work in collaboration with the following treatment groups in running our clinical trials:
For a listing of clinical trials involving patients at Mayo Clinic, see the Clinical Trials Web page. It lists clinical trials by condition, treatment, specialty, and Mayo Clinic location. This list includes only trials about which Mayo researchers have chosen to publish information. There may be other trials under way which are not part of this listing. Ask your doctor about clinical trials appropriate for your situation.